logo
Chubby isn't cute: Belly fat in kids linked to heart risk by age 10

Chubby isn't cute: Belly fat in kids linked to heart risk by age 10

Belly fat growth patterns in childhood are tied to insulin resistance, high blood pressure, and early heart disease risk by age 10, finds a decade-long Danish study presented at ECO 2025
New Delhi
Hi parents, have you ever shrugged off your child's growing tummy as just baby fat? New research from Denmark suggests it might be time to look a little closer. A large 10-year study titled Waist-to-height ratio trajectories from birth to age 10 years and cardiovascular risk markers found that kids with steadily increasing belly fat are more likely to show early warning signs of heart disease and Type 2 diabetes by age 10.
These findings were presented at the ongoing European Congress on Obesity (ECO 2025) in Malaga, Spain, and are raising questions about how we monitor children's health from the earliest years.
What does the study say about belly fat in children?
The study tracked 700 children from birth to age 10, measuring their waist-to-height ratio (WHtR) at 14 different checkups. Researchers identified three key belly fat growth patterns:
What is waist-to-height ratio and why does it matter?
Waist-to-height ratio is a simple metric: divide your child's waist circumference by their height. It's increasingly recognised as a better indicator of central obesity, excess fat around the belly, than body mass index (BMI).
The study found this ratio to be the strongest predictor of health risk. In fact, the child's belly size at age 10 was more important than the growth pattern over time. Where a child ends up in terms of belly size matters most.
What health risks are associated with central obesity in kids?
Central obesity is linked to dangerous conditions because this type of fat surrounds vital organs and contributes to:
Chronic inflammation
High blood pressure
Insulin resistance (linked to Type 2 diabetes)
Poor cholesterol levels
The slow-rising group had elevated levels of C-peptide, glycoprotein acetyls (GlycA), and high-sensitivity C-reactive protein (hs-CRP)—all markers linked to heart disease and metabolic dysfunction.
Is baby fat always harmless? When should parents worry?
Not all tummy chubbiness is cause for alarm. But if a child's belly keeps growing faster than their height over several years, it may be more than just baby fat.
The study highlights that early fat buildup can result in real metabolic changes, often going unnoticed until symptoms emerge later. Catching it early allows for simple interventions that can make a lifelong difference.
What can parents do to reduce the long-term health risks?
According to the researchers, you don't need fancy tests, just a tape measure and regular checkups. Here are some proactive steps:
Monitor waist-to-height ratio with help from your paediatrician
Encourage physical activity, at least 60 minutes of play daily
Promote a balanced diet, rich in whole foods and low in added sugar
Limit screen time and ensure kids get enough sleep
Model healthy habits as a family
When should preventive checks start for children?
The study suggests risk patterns begin as early as infancy or toddlerhood. That means:
Tracking belly size shouldn't wait until the school years
Paediatric visits could include waist checks, not just weight or BMI
Prevention strategies should ideally start before age 5
According to lead researcher Dr David Horner from the University of Copenhagen, 'We're not just looking at future problems—some children are already developing metabolic risk by age 10.'
Why waist-to-height ratio could change how we view childhood obesity
If your child's belly seems to be growing faster than the rest of them, it's not about body shaming or panic, it's about early action. This study reveals that health risks can develop quietly and early, often without obvious signs.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fermenting legumes, pulses can boost antioxidant, antidiabetic properties: Study
Fermenting legumes, pulses can boost antioxidant, antidiabetic properties: Study

Hans India

timean hour ago

  • Hans India

Fermenting legumes, pulses can boost antioxidant, antidiabetic properties: Study

New Delhi: Love to consume legumes and pulses? Fermenting them can help raise their antioxidant levels, as well as raise their ability to fight diabetes, according to a study. Food scientists at the University of Illinois Urbana-Champaign, US, identified the optimal fermentation conditions for pulses --the dried edible seeds of legumes -- that increased their antioxidant and antidiabetic properties and their soluble protein content. In the study, the team fermented pulses obtained from varying concentrations of black beans, black-eyed peas, green split peas, red lentils, and pinto bean flour. The fermentation was done using the bacteria Lactiplantibacillus plantarum 299v as microorganisms. The results showed that antioxidant activity increased by up to 83 per cent and their capacity to regulate Type 2 diabetes markers increased by 70 per cent. Fermentation also increased the amount of soluble protein in these food items. Red lentils and green split peas showed the greatest improvements in antioxidant scavenging activity and protein solubility. These also demonstrated the greatest modulation of two enzymes that improve insulin metabolism. Lp299v is a probiotic strain "containing microorganisms that support gut health," explained first author Andrea Jimena Valdés-Alvarado, a graduate student at the varsity. "After fermentation, it remains in the digestive process. It will not only preserve the fermented product that you're consuming, but it will also produce these peptides or amino acids that are more easily absorbed than the intact protein in the pulses," Valdés-Alvarado said. Further, Lp299v is also known to reduce inflammation, boost immunity, and enhance iron absorption, the team said, in the paper published in the journal Antioxidants. "These pulses contain between 18 per cent and 25 per cent good-quality proteins that can be used alone or as ingredients in other food products. We need to find adequate processing conditions and motivate the food industry to use them in dairy beverages or meat substitutes," said Elvira Gonzalez de Mejia, Professor of food science from the varsity. The researchers stressed the need to explore the sustainability of plant-based diets amid global food insecurity, shortages of natural resources, and climate change.

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand
Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand

Business Standard

time8 hours ago

  • Business Standard

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand

Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60 per cent in India in May from April in its second full month of being on offer in the South Asian country, which has the world's third-highest number of obese people. The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm Pharmarack Technologies. Sales of its 5 mg version more than doubled to about ₹7.5 crore, while revenue from the 2.5 mg shot was ₹5.1 crore. 'The patient number may have actually doubled' in May from April, Pharmarack Vice President Sheetal Sapale told Bloomberg News. The demand is gradually rising and should continue, she said. Newer patients are being introduced with the lower dose and upgraded to 5 mg injections after four weeks, according to Sapale. The increase in sales reflects the need for anti-obesity solutions in the vast market in India, where Danish rival Novo Nordisk A/S is also expected to launch soon. The country's generic drugmakers are awaiting the expiration of some patents from next year to unleash a flurry of copycat treatments. On Tuesday, Biocon Ltd. received approval for Liraglutide, a generic version of Novo Nordisk's type-2 diabetes and anti-obesity drug Victoza. India has about 100 million people living with diabetes and obesity each, Eli Lilly said earlier this year.

Study shows how blood sugar response to carbs can signal prediabetes risk
Study shows how blood sugar response to carbs can signal prediabetes risk

Hans India

time2 days ago

  • Hans India

Study shows how blood sugar response to carbs can signal prediabetes risk

New Delhi: Blood sugar responses after food, especially carbohydrates, may indicate metabolic health status as well as signal the risk of prediabetes, according to a study. Researchers from Stanford University in the US explained that the differences in blood sugar response patterns among individuals were associated with specific metabolic conditions such as insulin resistance or beta cell dysfunction -- both can lead to diabetes. The findings, published in Nature Medicine, suggest that this variability in blood sugar response could lead to personalised prevention and treatment strategies for prediabetes and diabetes. "This study suggests that not only are there subtypes within prediabetes, but also that your subtype could determine the foods you should and should not eat," said Michael Snyder, Professor in Genetics at Stanford Medicine. In the study, 55 participants without a history of Type 2 diabetes underwent metabolic testing for insulin resistance and beta cell dysfunction. The participants were also subjected to multi-omics profiling, which included tests for triglyceride levels, metabolites in the plasma of the blood, measures of liver function, and gut microbiome data. Just under half of the participants, 26 in total, had prediabetes. The results showed that many participants had a blood glucose spike after eating rice or grapes, regardless of their metabolic health status. The blood glucose responses to foods containing the highest amounts of resistant starch -- potatoes and pasta -- varied depending on the participants' metabolic dysfunction. Participants whose blood sugar spiked after eating bread were more likely to have hypertension or high blood pressure. The comparison of the blood glucose responses to potatoes versus grapes was associated with insulin resistance, suggesting that this ratio could serve as a real-world biomarker for insulin resistance in the future. "Such a biomarker would be useful because insulin resistance is amenable to lifestyle and medication interventions that can reduce the risk for diabetes in high-risk individuals. At present there is no easy way to diagnose it in the clinic," said Tracey McLaughlin, professor of endocrinology at the varsity. The researchers also found that eating fibre or protein before the rice lowered the glucose spike, and eating fat before the rice delayed the peak of the spike. However, these changes in blood glucose response occurred only in the metabolically healthy participants who were insulin-sensitive or had normal beta cell function, said the team calling for further research.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store